Login / Signup

Study design and baseline profile for adults with type 2 diabetes in the once-weekly subcutaneous SEmaglutide randomized PRAgmatic (SEPRA) trial.

John B BuseHelene Nordahl ChristensenBrian J HartyJulie MitchellBenjamin P SouleEmily ZacherleMark CzirakyVincent J Willey
Published in: BMJ open diabetes research & care (2023)
Keyphrases
  • phase iii
  • phase ii
  • study protocol
  • open label
  • double blind
  • placebo controlled
  • clinical trial
  • randomized controlled trial